More on CNTA

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-7.9% Growth)
- Ratings (4.7 Score)

Upcoming Events

- Earnings (8/17/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Centessa Pharmaceuticals (NQ:CNTA)
Delayed: 40.02 +0.15 (0.38%)
Prev. Close $39.87  
Open$39.87 
52 Wk High$ 
52 Wk Low$ 
Day High$40.07 
Day Low$39.78 
P/E N/A  
EPS$ 
Volume5,588,743 

Friends, Peers and Foes (?): 0ACX, ABBV, AMGN, GPCR, ARGX (more...)

Jun 12, 2026 04:16 PM Form 8-K Centessa Pharmaceuticals For: Jun 12
Jun 1, 2026 08:01 AM Actinium Pharmaceuticals names Steffen Heeger as chief medical officer
Jun 1, 2026 08:00 AM Actinium Appoints Accomplished Oncology Expert Steffen Heeger MD, MSc as Chief Medical Officer to Drive Rejuvenated Pipeline Development
May 22, 2026 04:17 PM Form 8-K Centessa Pharmaceuticals For: May 21
May 18, 2026 09:45 PM Form 4 Centessa Pharmaceuticals For: May 01 Filed by: Accardi Mario Alberto
May 15, 2026 04:40 PM Form SCHEDULE 13G Centessa Pharmaceuticals Filed by: Pentwater Capital Management LP
May 15, 2026 08:19 AM Form SCHEDULE 13G/A Centessa Pharmaceuticals Filed by: Avoro Capital Advisors LLC
May 13, 2026 09:02 AM Form SCHEDULE 13G/A Centessa Pharmaceuticals Filed by: Adage Capital Management, L.P.
May 7, 2026 07:01 AM Form DEFM14A Centessa Pharmaceuticals
May 6, 2026 11:07 AM Form SCHEDULE 13G/A Centessa Pharmaceuticals Filed by: FMR LLC
View All Articles

Entities mentioned with CNTA

View All Entities